NCT07191392

Brief Summary

To investigate the effect of Temporal Interference Stimulation (TIS) on associative memory (AM) in patients with depressive disorder

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Sep 2025Jun 2026

Study Start

First participant enrolled

September 1, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 24, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 10, 2026

Status Verified

December 1, 2025

Enrollment Period

9 months

First QC Date

September 10, 2025

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • face-word assciative memory task score

    In the face-cued word association test, participants viewed 12 grayscale photographs of faces on a computer screen, each shown for 4 seconds. Each photograph was paired with a distinct word, which participants read aloud when shown. Participants were instructed to memorize the word linked to each face. One minute later, participants viewed the same 12 faces in a new random order. They were then asked to recall the associated words. Each face was scored as correct or incorrect, and the total number of correct responses formed the AM score.

    baseline and immediately after the intervention

  • Change in Hamilton Depression Rating Scale (HAMD) Score

    The HAMD is a clinician-administered depression assessment and consists of 17 items with a total score range from 0 to 54. A higher score indicates a worse outcome.

    baseline and immediately after the intervention

  • Change in the Patient Health Questionnaire-15 (PHQ-15) scale

    The PHQ-15 is a 15-item scale to measure the severity of somatic symptoms, where each item is rated on a scale from 0 to 2. The PHQ-15 total score ranges from 0 to 30, with lower scores indicating less somatic symptoms.

    baseline and immediately after the intervention

Secondary Outcomes (2)

  • MRI measures

    baseline and immediately after the intervention

  • Dot-probe Task

    baseline and immediately after the intervention

Study Arms (2)

real stimulation

ACTIVE COMPARATOR

Participants will receive active TIS 10 to 14 times.

Device: Temporal Interference Stimulation (TIS)

sham stimulation

SHAM COMPARATOR

Participants will receive sham TIS 10 to 14 times.

Device: Sham temporal interference stimulation (TIS)

Interventions

The total stimulation duration was 30 minutes, including a 30-second current ramp-up at the beginning and a 30-second ramp-down at the end.

real stimulation

Sham stimulation had only 30 seconds of current ramping-up and ramping-down at the beginning and end of the stimulation, respectively, to simulate the sensation of actual stimulation

sham stimulation

Eligibility Criteria

Age12 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for depression, and HAMD\>17, BSS\>6, PHQ-15\>5.
  • the age ranged from 18 to 65 years old, and the length of education was more than 5 years.
  • the visual acuity or corrected visual acuity is normal, right-handed, can cooperate with the completion of various experimental tests.

You may not qualify if:

  • accompanied by severe somatic diseases, such as severe heart, liver, renal insufficiency and so on.
  • accompanied by other neurological diseases, such as stroke, epilepsy and so on. pregnant and lactating women.
  • accompanied by other mental disorders, such as drug abuse, schizophrenia, schizophrenic affective

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Anhui Medical University

Hefei, Anhui, China

RECRUITING

Anhui Mental Health Center

Hefei, Anhui, China

RECRUITING

MeSH Terms

Conditions

Depressive Disorder

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Central Study Contacts

Yanghua Tian, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice President of Anhui Medical University

Study Record Dates

First Submitted

September 10, 2025

First Posted

September 24, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 10, 2026

Record last verified: 2025-12

Locations